VGXI Inc. - cGMP Plasmid DNA Manufacturing Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • VGXI Inc. - cGMP Plasmid DNA Manufacturing's estimated annual revenue is currently $13M per year.(i)
  • VGXI Inc. - cGMP Plasmid DNA Manufacturing's estimated revenue per employee is $127,647

Employee Data

  • VGXI Inc. - cGMP Plasmid DNA Manufacturing has 102 Employees.(i)

VGXI Inc. - cGMP Plasmid DNA Manufacturing's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
Chief Accounting OfficerReveal Email/Phone
5
Director MarketingReveal Email/Phone
6
Director, MarketingReveal Email/Phone
7
Director ITReveal Email/Phone
8
Director, Business DevelopmentReveal Email/Phone
9
Assistant Project ManagerReveal Email/Phone
10
Senior ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M22852%N/AN/A
Add Company

What Is VGXI Inc. - cGMP Plasmid DNA Manufacturing?

VGXI Inc. is a leading provider of DNA plasmid manufacturing and development services for DNA vaccine and gene therapy research. The Company has an outstanding track record of success in manufacturing plasmid products under cGMP conditions for client companies' clinical studies in the US and Europe, and its cGMP and non-cGMP products have passed rigorous reviews by several international regulatory agencies. VGXI's ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. The recently announced research and pre-clinical production services extend the range of high-quality, research grade materials utilizing the same efficient service. This rapid turnaround program provides consistent materials to build a reliable pre-clinical dataset.

keywords:N/A

N/A

Total Funding

102

Number of Employees

$13M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

VGXI Inc. - cGMP Plasmid DNA Manufacturing News

2022-03-30 - VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prev

VGXI, Inc., a GeneOne company located in The Woodlands, Texas, is the global leading CDMO for cGMP DNA plasmid manufacture.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25M102-3%N/A
#2
$21.4M10215%N/A
#3
$22.3M1068%N/A
#4
$16.1M1077%N/A
#5
$35.6M108-4%N/A